PrintThe Burrill Report
Editor's Note: We are not publishing this week's usual deals column because this has been a holiday week for The Burrill Report. Nevertheless, below you will find the deal activity for the week ending December 30, 2011.
December 30, 2011
http://www.burrillreport.com/article-deals_for_the_week_ending_december_30_2011.html
DEALS
Deals for the Week Ending December 30, 2011
Table of announced transactions.[Please login to post comments]
- Osiris Wins Canadian Approval for World’s First Stem Cell Drug
Prochymal is only approved treatment for GvHD. Read More - A Venture Investor Cries Mea Culpa
The Burrill Report: May 21, 2012 Read More - Approvals of Innovative Drugs by FDA Surpass EU, Canada
Yale study challenges notion that the FDA lags behind its peers. Read More - Express Scripts Settles Employee Theft Charges
The weekly round-up of failed trials, missed targets, and other business mishaps. Read More - International Doctors' Group Criticizes Gates’ Global Vaccines Plan
Doctors Without Borders says strategy may fail to deliver. Read More - Agilent Acquires Dako for $2.2 Billion
Deal for Danish cancer diagnostic company is Agilent’s largest to date. Read More - Trial Seeks to Stop Alzheimer’s before it Starts
International collaboration undertakes expansive effort funded by NIH and industry. Read More - Kythera Files to Go Public Under JOBS Act
California company is the first biotech to take advantage of new law designed to make financing more accessible. Read More - Military Veterans Support Alternative Fuels
Retired generals warn Congress that national security is at risk. Read More - European Private Investment Fundraising Up 80 Percent
EVCA reports strong numbers despite economic turmoil in Europe. Read More
.gif)
.png){kind=small} |
 |